MX9301178A - Derivados de tetrahidropirimidina. - Google Patents

Derivados de tetrahidropirimidina.

Info

Publication number
MX9301178A
MX9301178A MX9301178A MX9301178A MX9301178A MX 9301178 A MX9301178 A MX 9301178A MX 9301178 A MX9301178 A MX 9301178A MX 9301178 A MX9301178 A MX 9301178A MX 9301178 A MX9301178 A MX 9301178A
Authority
MX
Mexico
Prior art keywords
hydrogen
lower alkyl
amino
group
treatment
Prior art date
Application number
MX9301178A
Other languages
English (en)
Inventor
Ralf Plate
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of MX9301178A publication Critical patent/MX9301178A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención está relacionada con un derivado de tetrahidropirimidina que tiene la fórmula I, en donde: R1 es hidrógeno; R2 es hidrógeno, un grupo alquilo inferior o acilo inferior; o R1 y R2 representan juntos una ligadura; R3 es hidrógeno, un grupo hidrocarburo inferior, opcionalmente sustituido con halógeno, CN, arilo o COR7; R4 es hidrógeno, un grupo alqu(en)ilo o arilo; R5 es hidrógreno, amino, amino sustituido con alquilo inferior, o un grupo alquilo inferior; y R6 es hidrógeno o metilo; R7 es amino, amino sustituido con alquilo inferior o un grupo alquilo inferior; o una sal farmacéuticamente aceptable del mismo. Los compuestos de la presente invención tienen propiedades muscarínicas y pueden ser usados para el tratamiento de trastornos del conocimiento y para el tratamiento de deficiencias colinérgicas.
MX9301178A 1992-03-04 1993-03-03 Derivados de tetrahidropirimidina. MX9301178A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200622 1992-03-04

Publications (1)

Publication Number Publication Date
MX9301178A true MX9301178A (es) 1993-09-01

Family

ID=8210467

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301178A MX9301178A (es) 1992-03-04 1993-03-03 Derivados de tetrahidropirimidina.

Country Status (11)

Country Link
US (1) US5470856A (es)
EP (1) EP0559279A1 (es)
JP (1) JPH05339245A (es)
KR (1) KR930019640A (es)
AU (1) AU661107B2 (es)
CA (1) CA2090170A1 (es)
FI (1) FI930934A (es)
MX (1) MX9301178A (es)
NO (1) NO930776L (es)
NZ (1) NZ247037A (es)
ZA (1) ZA931109B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612504C2 (de) * 1996-03-29 2003-10-23 Boehringer Ingelheim Kg Neue Wirkstoffkompositionen
US8853219B2 (en) 2010-01-11 2014-10-07 Neurosolis, Inc. Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
WO2012033956A1 (en) 2010-09-08 2012-03-15 Mithridion, Inc. Cognition enhancing compounds and compositions, methods of making, and methods of treating

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
IT1231237B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati eterociclici
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO930776D0 (no) 1993-03-03
KR930019640A (ko) 1993-10-18
JPH05339245A (ja) 1993-12-21
AU3393293A (en) 1993-09-09
NO930776L (no) 1993-09-06
AU661107B2 (en) 1995-07-13
CA2090170A1 (en) 1993-09-05
EP0559279A1 (en) 1993-09-08
FI930934A0 (fi) 1993-03-03
NZ247037A (en) 1995-10-26
US5470856A (en) 1995-11-28
FI930934A (fi) 1993-09-05
ZA931109B (en) 1993-09-22

Similar Documents

Publication Publication Date Title
TW375609B (en) 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
AR032621A1 (es) Compuestos derivados de tiofeno, metodo para su preparacion, composicion farmaceutica y uso en la fabricacion de medicamentos
HUP0203228A2 (hu) Szubsztituált indolszármazékok az NFKB-aktivitás módosítására, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ES2191484T3 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
YU48854B (sh) Derivati n-(4-piperidinil) (dihidrobenzofuran ili dihidro-2h-benzopiran)karboksamida i postupak za njihovo dobijanje
AR055592A1 (es) Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace)
DE58905637D1 (de) Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie.
AR006360A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
KR920014803A (ko) 인돌 유도체
AR005229A1 (es) Un derivado de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxaliil y una composicion farmaceutica que lo comprende.
AR062405A1 (es) Derivados de isoindol
CO4920250A1 (es) Compuestos heterociclicos utiles en la inhibicion de la spla2
AR012622A1 (es) Inhibidores de proteasas, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de los mismos en la fabricacion de unmedicamento
ES2161828T3 (es) Derivados de piperidina y agentes antiplaquetarios que los contienen.
AR015514A1 (es) Compuesto de amida, proceso para su preparacion y composicion farmaceutica que lo contiene
GB1086192A (en) Phenylcyclopropane derivatives
MX9301178A (es) Derivados de tetrahidropirimidina.
CO5180631A1 (es) Derivados de bencimidazol sustituidos con aminocarbonilo, procedimientos para su preparacion y su utilizacion como medicamentos
MX174210B (es) Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
BR0208823A (pt) Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica
UY23452A1 (es) Procedimiento para la preparacion de derivados de ciclohexano y tetrahidropirano
AR008826A1 (es) Derivados de xanteno y acridina, procedimiento para su preparacion y medicamentos que los contienen
PT728748E (pt) Novos derivados da benzodiazepina
DK0515462T3 (da) Indolderivater, fremgangsmåde til deres fremstilling samt anvendelse heraf